The Lancet. Respiratory Medicine INSIGHT FLU-IVIG Study Group 2019, ' Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG) : a double-blind, randomised, placebo-controlled trial ', The Lancet Respiratory Medicine, vol. 7, no. 11, pp. 951-963 . https://doi.org/10.1016/S2213-2600(19)30253-X